• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human RNA-binding protein with multiple splicing 2 (RBPMS2)

ACP15962

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP15962 Target NameRBPMS2
Target SynonymsRBPMS2; RBPS2_HUMAN; RNA binding protein with multiple splicing 2; RNA-binding protein with multiple splicing 2FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range2-209
Protein LengthFull Length of Mature ProteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ6ZRY4
Background Information
  • Uniprot Id

    Q6ZRY4

  • Target Species

    Human

  • Target Name

    RBPMS2

  • Target Full Name

    RNA-binding protein with multiple splicing 2

  • Target Function

    RNA-binding protein involved in the regulation of smooth muscle cell differentiation and proliferation in the gastrointestinal system. Binds NOG mRNA, the major inhibitor of the bone morphogenetic protein (BMP) pathway. Mediates an increase of NOG mRNA levels, thereby contributing to the negative regulation of BMP signaling pathway and promoting reversible dedifferentiation and proliferation of smooth muscle cells.

  • Target Subcellular Location

    Cytoplasm.

  • Target Synonyms

    RBPMS2; RBPS2_HUMAN; RNA binding protein with multiple splicing 2; RNA-binding protein with multiple splicing 2

Inquire Recombinant Human RNA-binding protein with multiple splicing 2 (RBPMS2) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification